Cladribine Intravenous and Insulin Glargine (U-300) Pens
Determining the interaction of Cladribine Intravenous and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cladribine
Brand name: Mavenclad, Leustatin
Synonyms: Cladribine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cladribine Intravenous-Insulin glargine and lixisenatide
- Cladribine Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Cladribine Intravenous-Insulin glargine, recombinant Subcutaneous
- Cladribine Intravenous-Insulin glulisine
- Cladribine Intravenous-Insulin Glulisine (Cartridges and Pens)
- Cladribine Intravenous-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Cladribine Tablets
- Insulin Glargine (U-300) Pens-Claforan
- Insulin Glargine (U-300) Pens-Claforan in D5W
- Insulin Glargine (U-300) Pens-Claravis
- Insulin Glargine (U-300) Pens-Clarifoam EF
- Insulin Glargine (U-300) Pens-Clarinex